Results 301 to 310 of about 5,397,691 (379)
Language Disparities in Continuous Glucose Monitoring for Type 2 Diabetes.
Rodriguez JA+8 more
europepmc +1 more source
Effect of SPTLC1 on type 2 diabetes mellitus. [PDF]
Yi B, Bao Y, Wen ZY.
europepmc +1 more source
Does Insulin Therapy Have a Hypertensive Effect in Type 2 Diabetes?
N. M. Genev+7 more
openalex +1 more source
Graphene‐PEDOT:PSS fillers revolutionize soft electronics by transforming jelly‐like materials into skin‐like systems with self‐healing, heat‐responsiveness, and multiplex sensing capabilities. This novel material exhibits exceptional printability, flexibility, and adhesiveness, enabling seamless integration into bioelectronics and tissue‐cyborganic ...
Morteza Alehosseini+7 more
wiley +1 more source
Housing Instability and Type 2 Diabetes Outcomes.
Berkowitz SA+9 more
europepmc +1 more source
High-resolution lifestyle profiling and metabolic subphenotypes of type 2 diabetes. [PDF]
Park H+11 more
europepmc +1 more source
This study identifies alnustone, a natural compound from Alpinia katsumadai, as a potent therapeutic agent for MASLD and MASH. Alnustone enhances mitochondrial fatty acid β‐oxidation by directly targeting calmodulin, improving liver steatosis, fibrosis, and insulin resistance in vivo.
Shourui Hu+13 more
wiley +1 more source
Are Individuals With Type 2 Diabetes Metabolically Inflexible? A Systematic Review and Meta-Analysis. [PDF]
Hansen M+3 more
europepmc +1 more source
The quantum dot integrated real‐time ELISA or QIRT‐ELISA system integrates a bead‐based quantum dot‐mediated immunoassay (BQI) with a modular microfluidic system to continuously monitor insulin and glucagon in whole blood samples and in a multiplexed setting.
Hesam Abouali+7 more
wiley +1 more source
Type 2 diabetes mellitus - conventional therapies and future perspectives in innovative treatment. [PDF]
Gieroba B, Kryska A, Sroka-Bartnicka A.
europepmc +1 more source